SCHEMBL9554754

SCHEMBL9554754

O=C(O)[C@H]1CCCN1C(=O)c1ncccc1O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 1/20 0.49
SPR P35270 1/20 0.49
ALDH1A1 P00352 3/20 0.48
SMN1; SMN2 Q16637 2/20 0.47
L3MBTL1 Q9Y468 1/20 0.45
DGAT1 O75907 3/20 0.45
NPSR1 Q6W5P4 1/20 0.43
ITGB3 P05106 1/20 0.42
ITGB1 P05556 1/20 0.42
ITGAV P06756 1/20 0.42
ITGA5 P08648 1/20 0.42
ITGA4 P13612 1/20 0.42
OPRM1 P35372 1/20 0.42
OPRD1 P41143 1/20 0.42
OPRK1 P41145 1/20 0.42
OGFRL1 Q5TC84 1/20 0.42
GYS1 P13807 1/20 0.42
TDP1 Q9NUW8 1/20 0.41
THRB P10828 1/20 0.41
ALOX12 P18054 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9554763 1.00 CA2 (0.49) CA2SPRALDH1A1SMN1; SMN2L3MBTL1
SCHEMBL9555317 1.00 CA2 (0.49) CA2SPRALDH1A1SMN1; SMN2L3MBTL1
SCHEMBL1921996 0.85 NPC1 (0.49) SPRALDH1A1L3MBTL1KMT2A
SCHEMBL10509618 0.81 SPR (0.46) SPRALDH1A1SMN1; SMN2
SCHEMBL845442 0.78 CYP2C9 (0.43) ALDH1A1KMT2A
SCHEMBL3168169 0.78 DGAT1 (0.58) CA2ALDH1A1SMN1; SMN2L3MBTL1DGAT1
SCHEMBL3168186 0.78 DGAT1 (0.58) CA2ALDH1A1SMN1; SMN2L3MBTL1DGAT1
SCHEMBL7852753 0.77 TDP1 (0.49) CA2ALDH1A1SMN1; SMN2L3MBTL1DGAT1
SCHEMBL3716813 0.77 ALDH1A1 (0.44) CA2ALDH1A1SMN1; SMN2L3MBTL1DGAT1
SCHEMBL19474987 0.77 ALDH1A1 (0.55) CA2ALDH1A1SMN1; SMN2L3MBTL1DGAT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5250517-A Hypotensive and cardiotonic agents; cardiac insufficiency HOFFMANN-LA ROCHE INC. (US) 1993-10-05 US disclosed
EP-0310918-A2 Peptide-like amino-acid derivatives F. HOFFMANN-LA ROCHE AG (CH) 1989-04-12 EP disclosed